Programma

 

Thursday - October 1, 2020
dalle 14.00 Accesso partecipanti
14.15-14.30 Meeting Introduction and Authority Salutations
Sergio Bracarda
14.30-15.00 Prostate Lecture Towards a Genomic Address in Prostate Cancer Landscape
Johann De Bono
mHSPC: Which Patients present with Advanced Disease and What We have to Do?
MODERATORI: Enrico Cortesi, Rodolfo Montironi
15.00-15.15 NGP (Next Generation Pathology): Which Data?
Alessia Cimadamore
15.15-15.30 NGI (Next Generation Imaging) Suggestions
Stefano Fanti/ Andrea Farolfi
15.30-15.45 NGT (Next Generation Treatments). Available Trial’ Data
Alberto Dalla Volta
15.45-16.00 NGS (Next Generation Sequencing): Where are We going?
Vincenza Conteduca
16.00-16.45 Open Discussion
Prostate Cancer “Melting Pot” Debate (AS, MØ CRPC, Sequencing Options, ..): Who treat, When and How ?
MODERATORI: Vittorio Donato, Giuseppe Procopio
16.45-17.00 NGP (Next Generation Pathology): Identifying Pathological predictor of aggressiveness for MØ CRPC Candidates to “Active Surveillance” or “Active Treatment
Matteo Brunelli
17.00-17.15 NGT (Next Generation Treatments): which 2nd Line CRPC Treatment selection between ARTAs and Docetaxel? Reflecting on the available prospective sequencing Data (CARD)
Orazio Caffo
17.15-17.30 NGT (Next Generation Treatments): PARP Inhibitors and Immuno-Oncology options in advanced Prostate Cancer, a Niche or more?
Michele Milella
17.30 – 18.00 Open Discussion
Friday - October 2, 2020
Urothelial Cancers: Towards a New Scenario
MODERATORI: Francesco Massari, Claudia Mosillo
14.00 – 14.15 NGP (Next Generation Pathology): Looking for innovative Urothelial Cancer Classifications considering eventual Druggable Targets
Carlo Patriarca
14.15 – 14.30 NGT (Next Generation Treatment): Where are We going in first line?
Claudia Caserta
14.30 – 14.45 NGT (Next Generation Treatment): which available and awaited data for the 2nd Lines in Advanced Disease?
Patrizia Giannatempo
14.45 – 15.00 Open Discussion
15.00 – 15.30 Urothelial Cancers Lecture What next for urothelial Cancers?
Tom Powles
Kidney Cancer Debate: Treatment Choice by Line and Prognostic Factors?
MODERATORI: Annalisa Guida, Roberto Sabbatini
15.30 – 15.45 NGP (Next Generation Pathology): what’s about Innovative Histological details also considering eventual Druggable Targets
Guido Martignoni
15.45 – 16.00 NGT (Next Generation Treatment): Optimal candidates to different Approaches in the 1st Line Setting
Camillo Porta
16.00 - 16.15 NGT (Next Generation Treatment): Which possible Options in the “new Following Lines” Scenario?
Roberto Iacovelli
16.15 – 16.30 Open Discussion & Round Table
  Advanced Kidney Cancer Lecture
16.30-17.00 May We speak of a possibility of a Cure?
Laurence Albiges
17.00-17.30 Critical Synthesis with Prize for the Best 2020 Communication in GU Oncology and salutation to the 9th WTC-GU 2021 Edition
17.30-18.00 Closing Remarks and Take home message